PERITONEAL METASTASES FROM COLORECTAL CANCER
Clinical trials for PERITONEAL METASTASES FROM COLORECTAL CANCER explained in plain language.
Never miss a new study
Get alerted when new PERITONEAL METASTASES FROM COLORECTAL CANCER trials appear
Sign up with your email to follow new studies for PERITONEAL METASTASES FROM COLORECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells target Stomach-Lining tumors in colorectal cancer
Disease control Recruiting nowThis early-phase study tests a new immunotherapy using a patient's own immune cells, engineered to recognize a protein called CEA on cancer cells. The treatment is given after surgery to remove visible tumors in the abdomen. The goal is to find a safe dose and see if it can delay…
Matched conditions: PERITONEAL METASTASES FROM COLORECTAL CANCER
Phase: PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated May 11, 2026 20:47 UTC
-
New blood markers could reveal hidden cancer after surgery
Knowledge-focused Recruiting nowThis study is looking at new blood tests to see if they can detect tiny bits of cancer left behind after surgery for colorectal cancer that has spread to the abdomen (peritoneal metastases). Currently, doctors rely on a visual check during surgery, but this may miss small amounts…
Matched conditions: PERITONEAL METASTASES FROM COLORECTAL CANCER
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated May 11, 2026 20:41 UTC